Abnormal Methylation Enzymes as the Most Critical Issue of Cancer
Ming C. Liau, Cristine L. Craig & Linda L. Liau · International Research Journal of Oncology · 2023
The objective of this study is to present convincing evidence to show that abnormal methylation enzymes (MEs) are the most critical issue of cancer, and to call for the acceptance of cell differentiation agent (CDA) formulations as the right medicines for cancer therapy. CDA form...
Open access
Research Article